Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025ChemMedChem

Delivery of a GPX4 Inhibitor by SN38 Prodrug Nanoassemblies for Amplified Antitumor Efficacy Based on Ferroptotic Chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLin LiYWYanyan WuWWWeiwei Wang

Discussion

Loading...

Member takes

Overview

Prodrug nanoassemblies improve antitumor effects in CT26 models, highlighting the role of ferroptosis in chemotherapy.

Key Points

  • ML210-loaded prodrug nanoassemblies exhibit superior antitumor effects in mouse models, indicating their potential in cancer therapy.
  • The nanoassemblies showed good stability and a GSH-responsive release profile, enhancing their therapeutic efficacy.
  • Prodrug nanoassemblies combined with ferroptosis inducers significantly activate nonapoptotic cell death mechanisms.
  • This strategy suggests a promising approach for developing more effective antitumor therapies using prodrugs.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68e70db790569dd607ee6759https://doi.org/10.1002/cmdc.202500667
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies2024 · 23 citations
  2. 2Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics2009 · 261 citations
  3. 3The progress and perspective of nanoparticle-enabled tumor metastasis treatment2020 · 149 citations
  4. 4Cancer statistics, 20252025 · 2,992 citations
  5. 5Emerging mechanisms and targeted therapy of ferroptosis in cancer2021 · 323 citations